Alphabet Inc. - TSCAN THERAPEUTICS INC ownership

TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 29 filers reported holding TSCAN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
Alphabet Inc. ownership history of TSCAN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,757,324
+2.4%
1,077,0800.0%0.18%
+22.1%
Q2 2023$2,692,700
+19.0%
1,077,0800.0%0.14%
+16.0%
Q1 2023$2,261,868
+37.3%
1,077,0800.0%0.12%
+30.2%
Q4 2022$1,647,932
-49.8%
1,077,0800.0%0.10%
-42.9%
Q3 2022$3,285,000
-3.0%
1,077,0800.0%0.17%
-8.7%
Q2 2022$3,387,000
+12.3%
1,077,0800.0%0.18%
+87.8%
Q1 2022$3,016,000
-37.8%
1,077,0800.0%0.10%
-16.2%
Q4 2021$4,847,000
-46.0%
1,077,0800.0%0.12%
-45.1%
Q3 2021$8,983,0001,077,0800.21%
Other shareholders
TSCAN THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
DC Funds, LP 630,000$1,323,00030.82%
Deer Management Co. LLC 1,245,505$2,615,5610.24%
Simplify Asset Management Inc. 546,916$1,148,5240.16%
Alphabet Inc. 1,077,080$2,261,8680.12%
Newtyn Management, LLC 236,800$497,2800.10%
DC Investments Management, LLC 35,563$74,6820.09%
Privium Fund Management (UK) Ltd 15,825$40,9870.03%
Baker Brothers Advisors 2,784,792$5,848,0630.03%
Tekla Capital Management LLC 200,000$420,0000.02%
NewEdge Wealth, LLC 91,463$192,0720.01%
View complete list of TSCAN THERAPEUTICS INC shareholders